Hello, I have a basic question. I am extracting samples that will be around 3.5 Mb and only done sonication on whole genome. Can I still use it with the smaller input or will I over fragment? Is enzymatic a better way to go?
Thanks
Thanks
-
-
Are you using Covaris? I think it wouldn't be a problem because you can regulate many things with the settings of the machine. I myself sonicated fragments around 100 to 10 kb end ended in the library range (300bp) with the settings given by Covaris. -
Large DNAs will fragment during isolation, so after isolation your 3.5 Mb DNA will most likely have the same fragment size distribution as you would get from purifying larger genomes. There should be no difference in further fragmentation (Covaris, other sonication, etc.) between the two. So, short answer, you shouldn't need to change any conditions for fragmenting.
Where things get tricky is on the low end. In our hands, Covaris works pretty well with fragments as small as ~1 kb, but smaller than that and you start to run into problems. 400 bp amplicons really don't fragment at all in the Covaris. I'm sure there is a good biophysical explanation for this, but we have just seen this empirically.Comment
-
Yes, planning on using Covaris. Thanks so much for your help!Comment
-
You may also want to try Fragmentase from NEBComment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment